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Abstract 
Background: Macrophages are a functionally heterogeneous cell population and depending on microenviron-
ments they polarize in two main groups: M1 and M2. Glutamic acid and glutamate receptors may participate in the 
regulation of macrophage plasticity. To investigate the role of glutamatergic systems in macrophages physiology, we 
performed the transfection of mGluR5 cDNAs into RAW-264.7 cells.
Results: Comparative analysis of modified (RAW-mGluR5 macrophages) and non-modified macrophages (RAW-
macrophages) has shown that the RAW-mGluR5 macrophages absorbed more glutamate than control cells and the 
amount of intracellular glutamate correlated with the expression of excitatory amino acid transporters -2 (EAAT-2). 
Besides, our results have shown that RAW-mGluR5 macrophages expressed a higher level of peroxisome proliferator-
activated receptor γ (PPAR-γ) and secreted more IL-10, high mobility group box 1 proteins (HMGB1) and Galectin-3 
than control RAW-macrophages.
Conclusions: We propose that elevation of intracellular glutamate and expression of mGluR5 may initiate the meta-
bolic rearrangement in macrophages that could contribute to the formation of an immunosuppressive phenotype.
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Background
Macrophages play an important role in host defense 
and maintenance of tissue homeostasis. Macrophages 
are a functionally heterogeneous cell population and 
depending on microenvironmental stimuli they polarize 
in two main groups: classically activated macrophages 
(or M1), whose activating stimuli are interferon-γ (IFN-
γ) and lipopolysaccharide (LPS), and alternatively acti-
vated macrophages (or M2), which comprise M2a (after 
exposure to IL-4 or IL-13) and M2c (after exposure to 
IL-10 or glucocorticoids) cells [1]. Microenvironmen-
tal components in blood plasma, including amino acids, 
can participate in macrophage polarization [2]. During 
inflammatory states, immune cells release amino acid 
glutamate (Glu) that induces chemotaxis and regulates 
endothelial barrier function [3, 4]. Extracellular Glu 
accelerated cell migration by activating class I/5 metabo-
tropic glutamate receptors (mGluR1/5), expression of 
which in the macrophages [5], as well as in the micro-
glia has been reported [6, 7]. In these cells, activation 
of mGluR5 by the selective agonist significantly reduces 
nitric oxide synthesis [6] and increases the secretion of 
anti-inflammatory IL-10 [8], suggesting that Glu and 
mGluR5 may be involved in the activity of an immuno-
suppressive type of macrophages. Besides, the high intra-
cellular concentration of glutamate can change the redox 
status and metabolism of innate cells through glutamate/
glutamine interconversion and glutathione (GSH) syn-
thesis. The glutamate/glutamine modules play a crucial 
role in M2 polarization through regulation of TCA cycle 
[9]. Similar alterations involve during differentiation of 
tumor-associated macrophages (TAM) [10].
At least two uptake systems are responsible for trans-
porting glutamate into immune cells: the excitatory 
amino acid transporters (EAAT) and the cystine/glu-
tamate exchanger (xCT). EAAT-mediated glutamate 
uptake enables a high glutamate concentration gradient 
to be maintained through the cell membrane, even if 
extracellular glutamate concentration rises. This gradient 
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stimulates the xc-system and leads to enhanced cystine 
uptake and GSH synthesis. Activation of EAAT reduced 
extracellular glutamate levels that may be significant for 
the prevention of neurological complications, as well as 
for cancer progression [11]. Macrophages in physiologi-
cal conditions do not express any of EAAT subtypes, 
however, in inflammatory conditions LPS and TNF-a 
increase EAAT expression [12]. It is interesting to note 
that in reactive astrocytes, acute up-regulation of glu-
tamate uptake through EAAT is mediated by mGluR5a 
activation [13].
Activation of mGluRs1/5 stimulates intracellular 
metabolism and gene expression by signaling through 
the Ras/ERK and PI3K/mTOR pathways. mTOR path-
way controls many metabolic processes in immune cells, 
including macrophage polarization [14, 15]. Among 
other regulatory proteins, mTOR promotes the expres-
sion and activity of peroxisome proliferator-activated 
receptor γ (PPAR-γ), a master regulator of lipid metabo-
lism [16]. PPAR-y transcriptionally regulates macrophage 
activation and polarization in health and disease [17]. In 
addition to the genes, participating in anti-inflammation 
and lipid metabolism, activation of PPAR-y increases glu-
tamate transporters expression [11, 18].
Among other microenvironmental compounds, high 
mobility group box 1 (HMGB1) could act as a modulator 
of macrophage homeostasis [19]. HMGB1 is a highly con-
served, non-histone chromosomal protein that play various 
roles in intracellular and extracellular processes. HMGB1 
present within the nuclei and is involved in the mainte-
nance of nucleosome structure and regulation of gene tran-
scription [20]. HMGB1 can also be actively secreted into 
the extracellular medium by a variety of immune and non-
immune cells such as macrophages, monocytes, neutro-
phils, dendritic cells and natural killer cells in response to 
various stimuli [21]. Extracellular HMGB1 promotes pro-
liferation, inflammation, energy metabolism, angiogenesis 
and inhibits host anticancer immunity, apparently through 
activation of interleukin-1/toll-like receptors (IL-1/TLRs) 
[22]. Recent investigations have shown that HMGB1 
enhances immune suppression through the production of 
IL-10 by myeloid-derived suppressor cells [23].
Another microenvironmental compound that can 
modulate the activity of macrophages is galectin-3 (Gal-
3). Gal-3 is a β-galactoside-binding lectin of 30 kDa that 
has been implicated in inflammation and fibrosis [24]. 
Gal-3 is highly expressed and secreted by macrophages, 
suggesting its significant role in the innate physiology 
[25, 26]. Gal-3 expression in macrophages is regulated 
by cytokines and various components of extracellular 
milieu. There is some evidence that short-term gluta-
mate treatment of microglia induced a marked increase 
in galectin-3 release [27].
Taking into account that microenvironmental compo-
nents modulate macrophage polarization, we hypoth-
esized that glutamate and mGluR5 might be the players 
in macrophage plasticity. To investigate the role of gluta-
matergic systems in macrophage activity, we performed 
the transfection of mGluR5 cDNAs into RAW-264.7 cells. 
Comparative analysis of these cells has shown that over-
expression of mGluR5 in macrophages leads to an eleva-
tion in the secretion of IL-10, to the increased expression 
of PPAR-y and the acceleration of HMGB1 and galectin-3 
release. These alterations are correlated with the levels 
of EAAT-2 and glutamate uptake. Our data suggest that 
glutamatergic systems and mGluR5 activation may par-




Mouse RAW 264.7 macrophages were obtained from 
the American Type Culture Collection (ATCC) and cul-
tured in plastic cell culture flasks (Greiner Bio One), at 
37 °C under 5% CO2/95% air in Dulbecco’s Modification 
of Eagle’s Medium (DMEM; ATCC) supplemented with 
10% (v/v) heat-inactivated fetal bovine serum (Sigma), 
100  U/ml penicillin (Gibco® by Life Technologies) and 
100  μg/ml streptomycin (Gibco® by Life Technologies). 
RAW 264.7 macrophages were used between passage 5 
and 15.
Cell transfection
Cells were passaged the day before electroporation. 
They were harvested in the exponential growth phase 
and centrifuged for 5  min at room temperature. After 
centrifugation cells were counted and resuspended in 
the appropriate Gene Pulser Electroporation Buffer 
(Bio-Rad). For electroporation was used mGluR5 plas-
mid DNA (from Oxford Genetics, UK) 20  μg/ml. As a 
reporter, Gaussia Luciferase gene was used. The mixture 
of cells and DNA was transferred to a cold electropora-
tion cuvette; the cuvette was placed in the ShockPod 
(Bio-Rad) and 100 μl of the cell mix was then subjected 
to electroporation using a single 20-ms pulse of 1750 V 
(RAW 264.7 cells). The transfection was performed 
using Gene Pulser Xcell Electroporation System (Bio-
Rad). After transfection cells immediately plated into 
pre-warmed media with supplements in a 6-well plate. 
Results were measured 48 h after transfection. For post-
transfection analysis, BioLux Gauassia Luciferase Assay 
kit (New England BioLabs; UK) and Western Blotting 
were used.
To confirm that observed plasticity resulted from 
the overexpression of mGluR5 and was not caused by 
electroporation, parallel controls for electroporation/
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transfection were used in each experiment): in the cell 
culture tubes instead, the plasmid-DNA the same vol-
ume of electroporation buffer was added. There were no 
significant differences between the non-transfected and 
transfected controls (data not shown).
Western blot analysis
Following the incubation in the presence or absence 
of different additions (40  μM Glutamate, 100  ng/
ml LPS, 20  nM IL-10), cells were removed from the 
dishes, washed with PBS and homogenized in 50  mM 
Tris–HCl, pH 7.4, containing protease inhibitors 
(1  mM PMSF, 5  mg/ml aprotinin, 5  mg/ml pepsta-
tin A, and 5 mg/ml leupeptin). 50 μg of proteins from 
the homogenate separated by SDS-PAGE on 15% gels. 
After electrophoresis, the proteins were transferred 
onto a nitrocellulose membrane (Mini-PROTEAN® 
Tetra Handcast Systems, BioRad). After blocking with 
5% bovine serum albumin and 0.05% Tween 20 in 
Tris–HCl buffered saline, the membranes were incu-
bated with the corresponding primary antibodies: 
anti-EAAT-2 (Abcam), anti-HMGB1 (Santa-Cruz Bio-
technology), anti-PPAR-γ (Abcam)) and immunoreac-
tivity was detected by enhanced chemiluminescence 
autoradiography (ECL kit; Santa-Cruz Biotechnology). 
Protein concentrations were determined using a BCA 
protein assay kit (Pierce).
Nitrite assays
The accumulation of nitrite was used as an index of 
NO production and inflammatory activation in general. 
Medium samples from cell cultures were incubated with 
an equal volume of Griess reagent at room temperature 
for 15 min and assessed for absorbance at 540 nm. Fresh 
culture medium served as the blank in all experiments.
Cytokine and glutamate detection
IL-10, HMGB1 protein, and galectin-3 were measured 
by ELISA according to the manufacturer’s protocol 
(Abcam). Plates were read at 450 nm using a microplate 
reader (Elx808, BioTek). For the measurement of the glu-
tamic acid, Glutamate Assay Kit (fluorimetric, Abcam) 
was used. Assay procedure was performed according 
to the manufacturer’s instructions. The fluorescence 
increase was monitored by using a fluorescence plate 
reader (Twinkle LB970, Berthold technology) at Ex/
Em—530–570 nm. Data are the mean ± SD of triplicate 
wells.
Statistical analysis
All data are presented as mean ± SEM. Statistical anal-
ysis was performed by one-way ANOVA followed by 
Scheffe’s post hoc comparison test. P < 0.05 was consid-
ered statistically significant.
Results
Effect of LPS and glutamate on NO and IL‑10 secretion
To clarify the role of mGluR5 in the activity of mac-
rophages, we conducted mGluR5 gene transfection in 
the murine RAW-264.7 cells. To verify the transfection, 
western blot of mGluR5 in the RAW 264.7 cells (RAW-
mGluR5) were performed. Unlike normal cells, the trans-
fected cells exposed a significant amount of mGluR5 
(Fig. 1a) and the level of mGluR5 does not change signifi-
cantly under the action of the LPS, nor after incubation 
of cells with IL-10. To characterize these macrophages, at 
first, we evaluated the ability of cells to release IL-10 and 
nitric oxide after LPS and glutamate treatments (Fig. 2). 
We have found that RAW-mGluR5, without LPS stimu-
lation, released more IL-10 (Fig.  2b) than control non-
transformed cells, while the amount of secreted nitric 
oxide did not change significantly (Fig.  2a). 40  μM glu-
tamate that corresponds to a concentration of glutamate 
in blood plasma has no effect on IL-10 release, secretion 
of NO or the viability of cells (24 h incubation, data not 
shown). Therefore, in future experiments, we used the 
DMEM medium enriched with 40  μM glutamate. The 
addition of LPS to the non-transfected macrophages did 
not change the secretion of IL-10, whereas, in RAW-
mGluR5, LPS resulted in a decrease in cytokine pro-
duction. Thus, these data showed that overexpression of 
mGluR5 in macrophages changes the secretion profile of 
IL-10.
Effect of mGluR5 transfection on the expression of EAAT‑2 
protein
It has been shown that 60–70% of mGluR5 may be local-
ized on intracellular membranes, where they can medi-
ate unique signaling effect [28]. However, the mechanism 
of the receptor’s activation by intracellular glutamate in 
macrophages is unknown. It is clear that the activation of 
this receptor depends on the concentration of intracellu-
lar glutamate, which, for its part, is regulated by the glu-
tamate transporters [28]. EAAT2 is the main supplier of 
glutamate in the macrophages, maintaining the high glu-
tamate gradient across the intra- and extracellular spaces 
[29]. To assess the role of mGluR5 in the EAAT expres-
sion, the level of EAAT2 were determined by western 
blotting. We have found that transfection of mGluR5 
cDNA in macrophages induces the expression of EAAT2 
(Fig. 1b, c). However, the significant differences between 
the effects of IL-10 and LPS are not revealed in the con-
trol non-transfected RAW-264.7 cells, because both LPS 
and IL-10 equally induces the expression of EAAT2.
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Effect of mGluR5 transfection on the glutamate uptake 
by RAW 264.7 cells
The expression of EAAT-2 could be correlated with the 
uptake of glutamate by macrophages. Therefore, in the 
next step, we determined the intracellular concentration 
of glutamate. Our results have shown that RAW-mGluR5 
cells contain more intracellular glutamate than control 
cells, and the treatment of transformed macrophages 
with IL-10 or LPS does not change the content of gluta-
mate significantly (Fig. 3). However, both, LPS and IL-10 
slightly increase the glutamate uptake in the control non-
transfected RAW macrophages. Thus, the amount of 
Fig. 1 Expression of mGluR5, EAAT-2, PPAR-γ and HMGB1 proteins in control and mGluR5-transfected macrophages. RAW 264.7 cells (RAW-NT) and 
mGluR5-transfected macrophages (RAW-mGluR5) (5–105 cells per well) were incubated with LPS (100 ng ⁄ ml) or IL-10 (20 nM) for 24 h, followed by 
the determination of EAAT-2 (b), PPAR-γ (d) and HMGB1 (f) expression by western blot analysis, as described in the “Methods” section. (h) β-Actin 
was also visualized by Western blotting to confirm equal loading of the fractions. Data shown are representative of three independent experiments. 
Quantification of EAAT2 blots shown in c, *P < 0.05, vs corresponding RAW-NT cells. Quantification of PPAR-γ shown in e, *P < 0.05, vs correspond-
ing RAW-NT cells, **P < 0.05, vs mGluR5 control. Quantification of HMGB1 blots shown in g, *P < 0.05, vs corresponding RAW-NT cells
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absorbed glutamate correlated with the levels of expres-
sion of EAAT-2 in macrophages.
Effect of mGluR5 transfection on the expression of PPAR‑γ
Activation of mGluR1/5 stimulates protein synthesis by 
signaling through the Ras/ERK and PI3K/mTOR path-
ways. mTOR promotes the expression and activity of var-
ious transcription factors, including PPAR-γ, [14] which 
in turn, can increase functional expression of the EAAT2 
[11]. To confirm the hypothesis that in the glutamate-
dependent EAAT2 expression, PPAR-γ may be involved, 
the content of PPAR-γ in the RAW-mGluR5 and RAW-
264.7 cells were determined. We have found that normal 
non-transfected RAW macrophages slightly express the 
PPAR-γ, whereas the transfection of mGluR5 cDNA in 
RAW-macrophages greatly increases the expression of 
PPAR-γ (Fig. 1d, e). It is interesting to note, that in trans-
fected macrophages, LPS reduce the PPAR-γ expression. 
These data suggest that the expression of EATT could 
modify the activity of PPAR-γ.
Effect of mGluR5 transfection on the HMGB1 and Gal‑3 
secretion
PPAR-γ activators exert anti-inflammatory activities in 
various cell types by interfering with proinflammatory 
signaling pathways [17]. HMGB1 exhibits a cytokine-
like function as a proinflammatory mediator when 
released from macrophages [21]. HMGB1 stimulated 
crosstalk between macrophages and myeloid-derived 
suppressor cells and increased the production of IL-10 
[23]. To examine the roles of mGluR5 in the regulation 
of HMGB1 release, we determined the content of intra- 
and extracellular HMGB1 in the RAW-mGluR5 and cell 
culture media after stimulation with LPS and IL-10. We 
have found that RAW-mGluR5 cells (Fig.  1f, g), as well 
as culture media of RAW-mGluR5 macrophages, con-
tain a higher level of HMGB1 than control cells (Fig. 4). 
LPS does not change either intracellular nor extracellu-
lar amount of HMGB1 after stimulation of normal cells, 
whereas IL-10 does not alter the amount of intracellular 
HMGB1 in both types of cells. IL-10 stimulates the secre-
tion of HMGB1 only in non-transfected cells, whereas in 
macrophages with overexpressed mGluR5, the sensitivity 
of cells to IL-10 was slightly dropped in compearison to 
LPS stimulated RAW-mGlur5 cells (Fig. 4a). Apparently, 
losing the sensitivity to the IL-10 may be associated with 
the increased synthesis of PPAR-γ in RAW-mGluR5, 
what has been described above.
Another cytokine that can be characterized the pheno-
type of the macrophage is galectin-3. This lectin releases 
Fig. 2 Effect of LPS and glutamate on NO and IL-10 secretion. RAW 264.7 cells (RAW-NT) and mGluR5-transfected macrophages (RAW-mGluR5) 
(5–105 cells per well) were incubated with LPS (100 ng ⁄ ml) or glutamate (40 μM) for 24 h, followed by determination of NO (a) and IL-10 (b) secre-
tion, as described in the “Methods” section. Data represented are mean ± SEM of results from four. separate experiments performed in duplicate. 
*P < 0.05, vs corresponding RAW-NT cells. **P < 0.05, vs RAW-mGluR5 control cells
Fig. 3 Effect of mGluR5 transfection on the glutamate uptake by 
RAW 264.7 cells. RAW 264.7 cells (RAW-NT) and mGluR5-transfected 
macrophages (RAW-mGluR5) (5–105 cells per well) were incubated 
with LPS (100 ng ⁄ ml) or IL-10 (20 nM) for 24 h, followed by the 
determination of glutamate in cell lysates, as described in the “Meth-
ods” section. Data represented are mean ± SEM of results from four 
separate experiments performed in duplicate. *P < 0.05, vs RAW-NT 
control cells
Page 6 of 9Shanshiashvili et al. Biol Res  (2017) 50:4 
by M2-type macrophages and feedback drives “alterna-
tive” macrophage activation [30]. Therefore, modulation 
of galectin-3 expression during macrophage differentia-
tion may be important in the regulation of macrophage 
plasticity. To investigate the role of mGluR5 in the galec-
tin-3 expression we treated RAW-mGluR5 and control 
RAW-macrophages with either LPS or IL-10 and meas-
ured the release of galectin-3 in culture media. We found 
that RAW-mGluR5 released the significantly higher 
amount of galectin-3 than control RAW-macrophages. 
In RAW-mGluR5 macrophages the Gal-3 secretion was 
decreased after treatment of cell with LPS (Fig.  4b). 
Treatment of macrophages with IL-10 does not change 
the release of galectine-3 neither in RAW-NT nor in 
RAW-mGluR5 macrophages.
Discussion
Macrophages that are present in all tissues are impor-
tant immune effector cells. Two main phenotypes of 
macrophages (M1 and M2) induce, suppress, or modu-
late both innate and adaptive immune responses. These 
phenotypes play a significant role in the pathophysiol-
ogy of cancer, autoimmunity and metabolic disorders 
[31]. M1 and M2 macrophages are determined by the 
microenvironment and can change in response to new 
stimuli [32, 33]. Among cytokines and other microenvi-
ronmental compounds in the blood plasma, Glu may be 
one of the modulators of macrophage/microglia plas-
ticity [9, 34, 35]. This amino acid plays a central role in 
amino acid metabolism, and its concentration in the 
plasma is regulated between 10 and 50  μM. Elevated 
plasma Glu has been reported in patients with a various 
type of pathologies, including malignancy and neurologi-
cal disorders, whereas low serum Glu was observed in 
certain autoimmune disorders. It has been proposed that 
increases in the plasma or serum Glu concentration cor-
relate with an immune deficiency, whereas decreases in 
plasma Glu concentration display immune hyper-reactiv-
ity [34].
The glutamatergic system in macrophages comprises 
glutamate receptors and glutamate transporters—
sodium-dependent EAAT2 and sodium-independent 
cystine/glutamate antiporter (a system called xc-) [29]. 
The macrophages, as well as microglia, express mGluR5 
[5], which is activated under both normal physiologi-
cal and pathophysiological conditions [7], however, the 
role of this system in macrophage/monocyte activation 
remains to be elicited. It has been reported that selec-
tive mGluR5 agonist reduces microglial activation and 
attenuate the release of pro-inflammatory mediators fol-
lowing stimulation with either LPS or interferon-γ (IFNγ) 
[6]. Apparently, this effect is due to shifting the balance 
between M1/M2 microglial activation states towards an 
M2 phenotype [36]. To clarify the role of the glutamater-
gic system in macrophages activation, we transfected 
mGluR5 cDNAs into macrophage-like RAW 264.7 cells. 
Our results have shown that mGluR5-overexpressed 
macrophages constitutively release more IL-10 than non-
transfected control cells and transfection of mGluR5 
cDNA into macrophages does not change the secretion 
of NO. This data suggests that expression of mGluR5 may 
contribute, at least in part, to the macrophage polariza-
tion towards to the M2 phenotype.
It has been shown that mGluR1/5 can function as an 
oncogene in certain cell types and that glutamatergic 
regulation may be significant in tumor progression [37]. 
The specific targets of mGluR5 in cancer cells, as well 
as in macrophages/microglia cell lines is not known. 
Fig. 4 Effect of mGluR5 transfection on the HMGB1 and Gal-3 secretion. RAW 264.7 cells (RAW-NT) and mGluR5-transfected macrophages (RAW-
mGluR5) (5–105 cells per well) were incubated with LPS (100 ng⁄ml) or IL-10 (20 nM) for 24 h, followed by the determination of HMGB1 proteins 
(a) and Gal-3 (b), as described in the “Methods” section. Data represented are mean ± SEM of results from four separate experiments performed in 
duplicate. *P < 0.05, vs RAW-NT control cells. **P < 0.05, vs RAW-mGlur5 control cells
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Activation of mGluRs1/5 stimulates intracellular metab-
olism and gene expression by signaling through the Ras/
ERK and PI3K/mTOR pathways. Since mTOR pathway 
controls many metabolic processes in immune cells, 
including macrophage polarization [14, 15] through the 
expression and activity of PPAR-γ, we hypothesized that 
mGluR5 might contribute to the regulation of PPAR-γ 
expression. Analysis of PPAR-γ in mGluR5-transfected 
and non-transected macrophages has revealed that over-
expression of mGluR5 increases the level of PPAR-γ. 
These data suggest that mGluR5 may be involved in mac-
rophage polarization through PPAR-dependent tran-
scription systems.
PPAR-γ controls the expression of several genes, 
including EAAT2 transporter [11]. EAAT2 is the main 
supplier of glutamate in the macrophages, maintaining 
the high glutamate gradient across the intra- and extra-
cellular spaces. The Glu transport via the EAATs directly 
provides intracellular Glu as a precursor for GSH syn-
thesis and assists inward cystine transport via cystine/
Glu exchanger (Xc-system) supporting intracellular 
GSH pool and maintaining intracellular redox balance. 
In the presence of high extracellular concentrations of 
glutamate, the cystine/glutamate antiporter functions 
in reverse, taking up extracellular glutamate and leading 
to cystine starvation, down-regulation of GSH synthesis 
and induction of oxidative stress [38]. These changes in 
redox regulation can alter the polarization and plastic-
ity of macrophages [39]. We have found that transfected 
RAW-mGluR5 cells express more EAAT2 than control 
cells and contain a higher amount of intracellular gluta-
mate. These data suggest that mGluR5, through the acti-
vation downstream effector systems, may be involved in 
PPAR-γ-dependent expression of EAAT2, which in turn 
increases the uptake of glutamate. Elevation of intracellu-
lar concentration of glutamate could reverse the cystine/
glutamate antiporter functions, leading to cystine starva-
tion, down-regulation of GSH synthesis and induction of 
oxidative stress that may drive M2 polarization of mac-
rophage [40].
PPAR-y could control macrophage polarization by sev-
eral pathways. Among other metabolic factors, PPARs 
induce an NAD+-dependent class III protein deacetylase 
(SIRT1) gene expression, which increases deacetylation of 
HMGB1 in the RAW 264.7 macrophages [41]. This modi-
fication decreases the LPS-induced release of HMGB1 
and changes the inflammatory response of macrophages. 
On the other hand, HMGB1 increases MDSC (myeloid-
derived suppressor cells)—macrophage crosstalk and 
production of IL-10, thereby skewing macrophages 
toward a type II tumor—promoting phenotype [23, 42]. 
Our results have shown that the intracellular level of 
HMGB1, as well as spontaneous release of HMGB1 from 
macrophages, increased after transfection of mGluR5. 
These data suggests that mGluR5-derived HMGB1 may 
be one of the major players in macrophage-MDSC cross-
talk [23].
Growing body of evidence have shown that Gal-3 
may be involved in immune tolerance and homeostasis 
[43]. In alternatively activated immunosuppressive mac-
rophages the level of Gal-3 expression was significantly 
higher than in classically activated macrophages, sug-
gesting that Gal-3 is a specific and highly upregulated 
marker of M2-type macrophages. Classical macrophage 
activation with LPS inhibits galectin-3 expression and 
release, whereas alternatively macrophage activation 
by IL-4/IL-13 leads to the accelerated biosynthesis and 
secretion of galectin-3 [30, 44]. Our data showed that 
administration of an mGluR5-encoding plasmid into 
macrophages increased the secretion of Gal-3 that 
reduces after treatment of cells with LPS. These data 
once again support the suggestion that overexpression of 
mGluR5 leads to a transition of the macrophages toward 
to M2 type.
Conclusions
In summary, our results suggest that extracellular gluta-
mate and mGluR5 could participate in the plasticity of 
macrophages by inducing the expression of PPAR-y and 
EAAT2. The increase in the intracellular concentration 
of glutamate, for its part, can lead to the rearrangement 
of oxidative metabolism and accelerate the plasticity of 
macrophages. Given that mGluR5 transfection induces 
the release of IL-10, change the secretion of HMGB1-
proteins and galectin-3, we propose that glutamatergic 
regulation of macrophages may participate in M-polar-
ization toward to immunosuppressive phenotype. This 
type of macrophage plasticity may contribute to the for-
mation of an anti-inflammatory response during tumor 
development.
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